20/20 GeneSystems, Inc. Release: New Multiplex Tissue Biomarker Technology Launched to Advance Personalized Medicine  
9/14/2010 11:52:33 AM

ARLINGTON, Va.--(BUSINESS WIRE)--20/20 GeneSystems, Inc. (“20/20” ) announced today at ADAPT 2010, an industry meeting focusing on advancing personalized medicine, the commercial launch of their patented technology for biomarker identification in tumors and other tissue samples. 20/20 is currently offering the technology to industry and academic researchers under service contracts.